Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 3510-3516, August 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorr, R. T.
Right arrow Articles by Liddil, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorr, R. T.
Right arrow Articles by Liddil, J. D.

Interactions of Mitomycin C with Mammalian DNA Detected by Alkaline Elution1

Robert T. Dorr2, G. Timothy Bowden, David S. Alberts and James D. Liddil

Departments of Medicine [R. T. D., D. S. A., J. D. L.] and Radiology [G. T. B.], Cancer Center Division, The University of Arizona, Tucson, Arizona 85724

The antitumor antibiotic mitomycin C (MMC) was studied in vitro using L1210 leukemia and 8226 human myeloma cells. Cytotoxicity was evaluated by colony formation in soft agar, and DNA damage was analyzed using alkaline elution filter assays. The purposes of these studies were: (a) to characterize the time course of MMC-DNA damage; (b) to characterize the type of DNA damage [DNA-DNA interstrand cross-links (ISC), DNA-protein cross-links (DPC), single and double strand breaks (SSBs, DSBs)]; and (c) to correlate this damage with cytotoxicity in vitro. Colony-forming assays showed the D0 value for 1 h MMC to be 15.0 µM for L1210 cells and 17 µM for 8226 cells. Alkaline elution studies showed that dose-dependent ISCs and DPCs formed rapidly following MMC exposure. Removal of cross-links was delayed, with only 50% repaired 32 h after exposure. There was a good correlation between ISCs and cytotoxicity in dose-response studies in each cell line. ISCs appeared to comprise most of the MMC-DNA lesions in both cell lines. No DNA SSBs or DSBs were observed following MMC exposure. Nuclei isolated from both cell lines and exposed to MMC produced less MMC alkylation than whole cells but, again, no strand breaks were evident. These results demonstrate that MMC is principally an alkylating agent when used at pharmacological (cytotoxic) concentrations in vitro. The lack of evidence for DNA strand breaks discounts a significant role for putative quinone-generated oxygen free radicals in the production of MMC cytotoxicity.

1 Supported in part by Grants CA 23074, CA 17094, CA 26972, and CA 17343 from the National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, MD 20205.

Presented in part at the Seventy-fifth Annual Meeting of the American Association for Cancer Research, May 10, 1984, Toronto, Canada (14).

2 To whom requests for reprints should be addressed, at Cancer Center, Arizona Health Sciences Center, 1501 N. Campbell Avenue, Tucson, AZ 85724.

Received 12/14/84. Revised 4/24/85. Accepted 4/26/85.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
J.-C. Ko, S.-C. Ciou, C.-M. Cheng, L.-H. Wang, J.-H. Hong, M.-Y. Jheng, S.-T. Ling, and Y.-W. Lin
Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells
Carcinogenesis, July 1, 2008; 29(7): 1448 - 1458.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
H. I. Abdel-Halim, A. T. Natarajan, L. H. F. Mullenders, and J. J. W. A. Boei
Mitomycin C-induced pairing of heterochromatin reflects initiation of DNA repair and chromatid exchange formation
J. Cell Sci., April 15, 2005; 118(8): 1757 - 1767.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Ochs, R. W. Sobol, S. H. Wilson, and B. Kaina
Cells Deficient in DNA Polymerase {beta} Are Hypersensitive to Alkylating Agent-induced Apoptosis and Chromosomal Breakage
Cancer Res., April 1, 1999; 59(7): 1544 - 1551.
[Abstract] [Full Text] [PDF]


Home page
J Oncol Pharm PractHome page
R. T. Dorr and J. D. Liddil
Stability of mitomycin C in different infusion fluids: Compatibility with heparin and glucocorticosteroids
Journal of Oncology Pharmacy Practice, January 1, 1995; 1(3): 19 - 24.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.